Filtered By:
Source: Heart Rhythm
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 406 results found since Jan 2013.
Po-685-06 liver cirrhosis is associated with an increase in bleeding and mortality in patients undergoing left atrial appendage occlusion: insights from a nationwide cohort analysis
Patients with liver cirrhosis are at an increased risk of bleeding secondary to diminished clotting factor synthesis. In patients with both atrial fibrillation (AF) and cirrhosis, there is an additional risk of cardioembolic stroke. Thus, left atrial appendage occlusion (LAAO) is an attractive therapeutic option. There is limited data available that examine the safety and outcomes of LAAO in patients with cirrhosis.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Sahith Reddy Thotamgari, Aakash Sheth, Samarthkumar Thakkar, Harsh P. Patel, Abhishek J. Deshmukh, Christopher V. DeSimone Source Type: research
Po-684-05 a cha ₂ds₂-vasc score of 2 and above predicts stroke risk in atrial flutter-a retrospective study from the national inpatient sample
The CHA ₂DS₂-VASc score is widely used to determine the stroke risk in atrial fibrillation (AF) patients. Although clinicians use the CHA₂DS₂-VASc score to determine the stroke risk in atrial flutter (AFL) patients, the use of the CHA₂DS₂-VASc score in AFL has not been well studied.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Kavin Raj, Suyansh Sharma, Rangadham Nagarakanti, Umesh Bhagat Source Type: research
Po-684-02 lower rate of major bleeding in high-risk patients undergoing left atrial appendage occlusion: a propensity matched comparison with direct oral anticoagulation
Stroke prophylaxis in very high risk (CHA2DS2-VASc ≥ 5) patients with atrial fibrillation (AF) is one of the major challenges faced by physicians. Specifically, initiating direct oral anticoagulants (DOACs) in these patients poses a therapeutic conundrum due to the concomitant high risk of bleeding. Left atrial appendage occlusion (LAAO) might be a potential alternative for thromboembolic (TE) prevention; however, there are no studies comparing these two strategies in very high-risk patients.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Michele Magnocavallo, Domenico G. Della Rocca, Marco Schiavone, Marco Valerio Mariani, Giampaolo Vetta, Carola Gianni, Sanghamitra Mohanty, Mohamed A. Bassiouny, Carlo Lavalle, Giovanni FORLEO, J. David Burkhardt, Amin Al-Ahmad, G. Joseph Gallinghouse, Ro Source Type: research
Po-614-05 a community hospital review of watchman outcomes to determine safe discharge protocols
Left atrial appendage occlusion (LAAO) devices are increasingly used to decrease the risk of stroke in atrial fibrillation patients with contraindication to oral anticoagulation. Discharge protocols after this procedure are variable, and same day discharge (SDD) may improve inpatient bed utilization.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Jill Boone Schaeffer, Diane N. Bollinger Source Type: research
En-571-02 screening for putative pathogenic variants in dilated cardiomyopathy genes identifies early disease and predicts mortality
Dilated cardiomyopathy (DCM) can present with the sentinel event of sudden cardiac death, as well as heart failure, ECG abnormalities, atrial fibrillation or stroke. Data are limited regarding genetic screening and the mortality associated with DCM in a general population.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Ravi Shah, Babken Asatryan, Ghaith Sharaf Dabbagh, Mohammed Khanji, Stefan van Duijvenboden, Daniele Muser, Andrew Paul Landstrom, Christopher Semsarian, Virend Somers, Patricia B. Munroe, Anwar A. Chahal Source Type: research
Ap-519-04 development of the atrial fibrillation “behavioral cha2ds2-vasc” in electrophysiology clinics
AF etiology, recurrence, and burden are influenced by both modifiable and non-modifiable risk factors spanning biological, behavioral, and demographic factors. There is increased interest in understanding and measuring behavioral risk factors (e.g., alcohol, sedentariness, smoking) associated with AF, to reduce stroke risk. An efficient measure of lifestyle factors in AF would allow for rapid clinical assessment and appropriate patient education and referral.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Scarlett Anthony, Rebecca Harrell, Saleen Khan, Yumi Ha, Ahmed Hassaan Qavi, Irion W. Pursell, Aditi Naniwadekar, Kevin Travia, Matthew Whited, Samuel F. Sears Source Type: research
Ce-543-04 inter-atrial block identifies patients with low cha2ds2-vasc score but high stroke risk
Beyond current methods of risk stratification, clinical studies employing machine learning methodology have demonstrated that the 12-lead ECG harbors additional prognostic information for various cardiovascular outcomes. Interatrial block (IAB) manifests as P wave duration>120 msec and is associated with thromboembolism, atrial arrhythmias, and mortality.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Joshua Lampert, Shreyas Havaldar, David Power, Marc A. Miller, Abhishek Maan, Kartikeya Menon, Emmanuel Ekanem, Jonathan Gandhi, Daniel N. Pugliese, Daniel Ross Musikantow, Mohit K. Turagam, Valentin Fuster, Srinivas R. Dukkipati, Benjamin Glicksberg, Viv Source Type: research
Ce-543-03 early rhythm control in patients with incident atrial fibrillation who had a prior history of stroke: a nationwide population-based cohort study
Early rhythm control therapy has been demonstrated to be associated with a lower risk of stroke compared to usual care in patients with atrial fibrillation (AF). However, there are limited data regarding the benefit of early rhythm control therapy for secondary prevention for stroke in patients with AF.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: So-Ryoung Lee, Eue-Keun Choi, Seil Oh, Gregory Lip Source Type: research
Ce-543-01 4-fold higher rate of atrial fibrillation detection after stroke of presumed known etiology with continuous versus intermittent monitoring: results from the stroke af study
In patients (pts) with recent ischemic stroke, atrial fibrillation (AF) may be common regardless of the stroke etiology. Timely diagnosis and intervention may prevent more disabling recurrent strokes.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Jonathan P. Piccini, Christopher Granger, Richard A. Bernstein, Hooman Kamel, Jeffrey Katz, pramod P. sethi, Evgeny Sidorov, Scott E. Kasner, Scott B. Silverman, Theodore Merriam, Paul Ziegler, Lee Schwamm Source Type: research
Hp-574-04 associations between obesity parameters and the risk of incident atrial fibrillation and ischemic stroke in different age groups: a nationwide population-based study
Atrial fibrillation (AF) and ischemic stroke (IS) are two representative cardiovascular diseases. They share common metabolic risk factors such as obesity and ageing is an important predisposing factor. Limited data comprehensively evaluated the relationship between obesity measurements - body mass index (BMI) and waist circumference (WC) - and incident AF and IS in the different age groups.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Hyo-Jeong Ahn, So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Sun-hwa Kim, Seil Oh, Gregory Lip Source Type: research
Hp-574-03 new-onset bleeding and subsequent risk of cardiovascular outcomes in anticoagulated patients with atrial fibrillation
The use of oral anticoagulation for stroke prevention in patients with atrial fibrillation (AF) increases their risk of bleeding. The prognosis of AF patients who experience a bleeding event is not well studied.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Pascal Meyre, Rebecca E. Paladini, Elisa Hennings, Stefanie Aeschbacher, Tobias Reichlin, Nicolas Rodondi, Annina Stauber, Andreas M üller, Giorgio Moschovitis, Giulio Conte, Angelo Auricchio, Matthias Schwenkglenks, Michael Kühne, Stefan Osswald, David Source Type: research
Ca-532-03 association between sleep apnea, atrial fibrillation and incident stroke in a very large population of young individuals
Sleep apnea (SA) worsens outcomes in patients with atrial fibrillation/flutter (AF), and both are common in young patients (20-50 years). However, it is unreported what proportion of young patients with SA have or will develop AF or stroke.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Sunil K. Vasireddi, Brototo Deb, Prasanth Ganesan, Ruibin Feng, Albert Joseph Rogers, Tina Baykaner, Neal Kumar Bhatia, Paul Clopton, Sanjiv M. Narayan Source Type: research
Po-693-03 atrial fibrillation in cryptogenic stroke: a real-world study with insertable cardiac monitor
Patients with cryptogenic stroke (CS) undergo insertable cardiac monitor (ICM) screen for occult atrial fibrillation (AF) as a possible ischemic stroke etiology. Continuous monitoring with ICM was shown to be superior to intermittent cardiac monitoring in the detection of AF in the CRYSTAL-AF Trial. However, there is limited real-world data about the rate of AF detection using ICM in patients with cryptogenic stroke.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Payam Safavi-Naeini, Erica Kim, Joanna E. Molina Razavi, Mohammad Saeed, Abdi Rasekh, Mehdi Razavi, Mihail G. Chelu Source Type: research
Ce-539-02 utilization of oral anticoagulation after bleeding events in stroke patients with atrial fibrillation
Oral anticoagulation (OAC) is recommended for stroke prophylaxis after diagnosis of atrial fibrillation (AF). However, the optimal strategy or timing for continuing OAC use after bleeding events in these patients has not been well established.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Paul Ziegler, shadi yaghi, Candace Gunnarsson, Michael Ryan, Sarah Rosemas, Matthew R. Reynolds Source Type: research
Ce-538-03 incidence, predictors, and clinical outcomes of peri-device leak in subjects undergoing transcatheter left atrial appendage closure in the amulet ide trial
The Amulet IDE trial is a prospective, global, randomized (1:1) trial of the Amplatzer ™ Amulet™ LAA occluder (Abbott) versus the Watchman™ LAA closure (LAAC) device (Boston Scientific) in subjects with non-valvular AF. Mismatch between LAA anatomy and LAAC device can result in peri-device leaks (PDLs). The association of PDL to stroke has been unclear.
Source: Heart Rhythm - April 29, 2022 Category: Cardiology Authors: Christopher R. Ellis, Matthew Price, Jens Erik Nielsen-Kudsk, David Thaler, Nigel Gupta, Konstantinos Koulogiannis, Dhanunjaya R. Lakkireddy Source Type: research
